Rongcan Biotech

Shanghai, China · Founded 2020 · Privately Held (backing)

Developer of mRNA-based pharmaceutical products designed for nucleic acid-based therapeutics. Rongcan Biotech is based in Shanghai, China and was founded in 2020. It has raised $13.8 million.

Last price · $/share

—

Implied valuation

—

Total raised

$13.8M

Last round

—

How much has Rongcan Biotech raised?

$13.8Macross 0 recorded rounds

Free account

More of Rongcan Biotech with a free account

·Watch Rongcan Biotech: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Rongcan Biotech investors

9 investors are on record for Rongcan Biotech, including Anhui Investment Group Holdings, Guangzhou Yuexiu Industrial Investment Fund Management, Hangzhou Huafang Chuangliang Investment Management and Shaanxi Growth Enterprise Guide Fund.

For fundraisers

Raising for a company like Rongcan Biotech?

9 investors have backed Rongcan Biotech.

See all 9 investors →

Frequently asked about Rongcan Biotech

How much has Rongcan Biotech raised?: Rongcan Biotech has raised $13.8M in total across 0 recorded funding rounds.